¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ¿¹Ãø(-2031³â) : Áö¿ªº° ºÐ¼® - À¯Çüº°, ¿ëµµº°
Asia Pacific Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application
»óǰÄÚµå : 1637687
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 89 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,450 £Ü 4,781,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 4,450 £Ü 6,166,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,450 £Ü 7,552,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀº 2023³â¿¡ 11¾ï 574¸¸ ´Þ·¯·Î 2031³â¿¡´Â 34¾ï 1,789¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 15.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹æ»ç¼± Á¾¾çÇп¡ ´ëÇÑ Àü·«Àû ³ë·ÂÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ¼ºÀå ÃËÁø

¹æ»ç¼± Á¾¾çÇÐÀº ¾Ï Ä¡·á¿¡ ÀÖ¾î Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦Ç° °³¹ß, ±â¼ú Çõ½Å, Á¦Ç° Ãâ½Ã, Á¦Ç° ½ÂÀÎ, ÇÕº´, Àμö, Á¦ÈÞ µî ½ÃÀå ±â¾÷µéÀÇ ²÷ÀÓ¾ø´Â ¹æ»ç¼± Ä¡·áÀÇ ÁøÈ­°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÖ±Ù ÀÌ ½ÃÀå¿¡¼­ ÁøÇàµÈ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê Áß ÀϺθ¦ ¼Ò°³ÇÕ´Ï´Ù.

µû¶ó¼­ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇÏ´Â ½ÃÀå ±â¾÷µé »çÀÌ¿¡¼­ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­ÇÏ°í ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå¿¡¼­ ÃæºÐÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå °³¿ä

¹æ»ç¼± Á¾¾çÇÐ ºÐ¾ß´Â ±â¼ú ¹ßÀü°ú ÇÔ²² Áß±¹¿¡¼­ ºü¸£°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ¹æ»ç¼± Á¾¾çÇÐ ½Ã½ºÅÛ¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀÌ´Â µ¥ ÀÖ¾î ÇÕÀÛÅõÀÚ°¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Áß±¹ µ¿À§¿ø¼Ò ¹× ¹æ»ç¼± °ø»ç(China Isotope and Radiation Corporation, CIRC)¿Í ¹Ì±¹ÀÇ ¹æ»ç¼± Ä¡·á ½Ã½ºÅÛ °³¹ß ¾÷üÀÎ Accuray´Â 2019³â 1¿ù¿¡ ÇÕÀÛȸ»ç¸¦ ¼³¸³Çß½À´Ï´Ù. ÀÌ ÇÁ·ÎÁ§Æ®´Â AccurayÀÇ ÃÖ÷´Ü Ä¡·á ¼Ö·ç¼Ç°ú ÇöÁö Á¦Á¶ ´É·ÂÀ» Ȱ¿ëÇÏ¿© Áß±¹ ½ÃÀåÀÇ ¹ÌÃæÁ· ¼ö¿ä¸¦ ÃæÁ·½Ãų °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀÌ´Ï¼ÅÆ¼ºê´Â Áß±¹ ³» ¹æ»ç¼± Á¾¾çÇÐ ±â¼ú °³¹ß¿¡ ´ëÇÑ Áß±¹ÀÇ Çå½ÅÀ» º¸¿©ÁÖ´Â °ÍÀ¸·Î, ÇâÈÄ ¸î ³â µ¿¾È ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå¿¡¼­ ÁÖ¸ñÇÒ ¸¸ÇÑ Àü¸ÁÀ» âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ¼öÀÍ ¹× 2031³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ¼¼ºÐÈ­

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀº À¯Çü, ¿ëµµ ¹× ±¹°¡º°·Î ºÐ·ùµË´Ï´Ù.

À¯Çüº°·Î º¸¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀº ¿ÜºÎ ¹æ»ç¼± Ä¡·á¿Í ³»ºÎ ¹æ»ç¼± Ä¡·á·Î ³ª´µ¸ç, 2023³â ½ÃÀå Á¡À¯À²Àº ¿ÜºÎ ¹æ»ç¼± Ä¡·á ºÐ¾ß°¡ ´õ Å« ºñÁßÀ» Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀº À¯¹æ¾Ï, Àü¸³¼±¾Ï, Æó¾Ï, µÎ°æºÎ¾Ï, ÀڱðæºÎ¾Ï, ±âŸ·Î ºÐ·ùµÇ¸ç, 2023³â¿¡´Â À¯¹æ¾Ï ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀº Áß±¹, ÀϺ», Àεµ, Àεµ, È£ÁÖ, Çѱ¹, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀ¸·Î ºÐ·ùµÇ¸ç, 2023³â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå Á¡À¯À²Àº Áß±¹ÀÌ ¾ÐµµÀûÀÎ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide(ION Beam Applications SA), Becton Dickinson and Co, Mevion Medical Systems NTP RADIOISOTOPES,Mallinckrodt Plc,Panacea Medical Technologies Pvt.Ltd ¹× CuriumÀº ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷ Áß ÀϺÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦5Àå ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå : ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®

Á¦6Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå : ±¹°¡º° ºÐ¼®

Á¦9Àå ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå : ¾÷°è »óȲ

Á¦10Àå ±â¾÷ °³¿ä

Á¦11Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Asia Pacific radiation oncology market was valued at US$ 1,105.74 million in 2023 and is expected to reach US$ 3,417.89 million by 2031; it is estimated to record a CAGR of 15.1% from 2023 to 2031.

Strategic Initiatives in Radiation Oncology Boost Asia Pacific Radiation Oncology Market

Radiation Oncology holds tremendous potential in cancer treatment. Additionally, constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. Some of the recent strategic initiatives taken place in the market are

Therefore, surging strategic initiatives among market players operating in radiation oncology market which are expected to amplify the market growth and create ample opportunities for the radiation oncology market.

Asia Pacific Radiation Oncology Market Overview

The field of radiation oncology has been developing quickly in China due to significant technological advancements. Joint ventures have played a crucial role in increasing the accessibility of radiation oncology systems. With these initiatives, companies also focus on developing high-tech therapy products. China Isotope and Radiation Corporation (CIRC) and Accuray, a US-based developer of radiotherapy systems, established a joint venture in January 2019. This project uses Accuray's cutting-edge treatment solutions and local manufacturing capabilities to address the unmet needs in the Chinese market. Such initiatives demonstrate China's dedication to developing radiation oncology skills within the country, which would generate noteworthy prospects for the radiation oncology market in the coming years.

Asia Pacific Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Radiation Oncology Market Segmentation

The Asia Pacific radiation oncology market is categorized into types, application, and country.

Based on types, the Asia Pacific radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the Asia Pacific radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the Asia Pacific radiation oncology market is segmented into the China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Panacea Medical Technologies Pvt. Ltd,, and Curium are some of the leading companies operating in the Asia Pacific radiation oncology market.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Asia Pacific Radiation Oncology Market - Key Market Dynamics

5. Radiation Oncology Market - Asia Pacific Market Analysis

6. Asia Pacific Radiation Oncology Market Analysis - by Types

7. Asia Pacific Radiation Oncology Market Analysis - by Application

8. Asia Pacific Radiation Oncology Market - Country Analysis

9. Radiation Oncology Market - Industry Landscape

10. Company Profiles

11. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â